Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Issue Archive

Table of Contents

BLOOD ADVANCES TALK

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

PLATELETS AND THROMBOPOIESIS

TRANSPLANTATION

Jurjen Versluis,Myriam Labopin,Annalisa Ruggeri,Gerard Socie,Depei Wu,Liisa Volin,Didier Blaise,Noel Milpied,Charles Craddock,Ibrahim Yakoub-Agha,Johan Maertens,Per Ljungman,Anne Huynh,Mauricette Michallet,Eric Deconinck,Patrice Chevallier,Jakob Passweg,Fabio Ciceri,Mohamad Mohty,Jan J. Cornelissen,Arnon Nagler,on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT),on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

VASCULAR BIOLOGY

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals